KRAS and cancer: For cancer treatment, siRNA targets include genes critically important for growth of tumors, such as S100A4, c-Met, PAK4, KRAS, etc. Of note, currently a phase 1 clinical trial of metastatic pancreatic adenocarcinoma treatment by MSC-derived exosomes with siRNA to mutated KRAS is in progress [NCT03608631].